Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Overview
Diabetes Therapy is a comprehensive journal dedicated to advancing knowledge in the field of diabetes and related disorders. It focuses on research, treatment, and education, providing a platform for scientists, clinicians, and educators to share their findings and insights. With a multidisciplinary approach, this journal aims to improve the understanding, management, and prevention of diabetes, ultimately enhancing the quality of life for individuals affected by this chronic condition.
Details
Details
Abbr.
Diabetes Ther
Start
2010
End
Continuing
p-ISSN
1869-6953
e-ISSN
1869-6961
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 7077
52
SJR / Ranks: 4232
938
CiteScore / Ranks: 3827
6.00
JIF / Ranks: 2461
3.8
Recent Articles
11.
Wangnoo S, Baruah M, Lodha S, Sanyal D, Goyal R, Sooragonda B, et al.
Diabetes Ther
. 2025 Feb;
PMID: 40014293
Introduction: Hyperglycemia is a common and challenging condition in hospitalized patients both with and without a history of diabetes. Managing hyperglycemia effectively is critical in reducing complications, mortality, and the...
12.
Gordon C, Graf M, Hopley C, Jennings P, Littlewood M
Diabetes Ther
. 2025 Feb;
PMID: 39969756
Introduction: There is currently a limited understanding of the process of initiating standard insulin pump therapy (IPT) and how this differs with pump type. A time-and-motion study was conducted in...
13.
Elnaggar M, Mansinho J, Malkin S, Whitaker J, Hunt B, Glah D, et al.
Diabetes Ther
. 2025 Feb;
PMID: 39969755
Introduction: Glucagon-like peptide-1 (GLP-1) receptor agonists represent efficacious therapies for treating type 2 diabetes. Oral semaglutide is the only orally administered GLP-1 receptor agonist currently available and has been associated...
14.
Shaikh S, Sharma S, Phatak S, Asirvatham A, Bhattacharyya S, Dhandhania V, et al.
Diabetes Ther
. 2025 Feb;
PMID: 39969754
Introduction: Imeglimin is a novel oral antidiabetic drug that was approved for use in India in October 2022. Thus far, no large-scale studies on the effectiveness and safety of imeglimin...
15.
Hamamoto Y, Oura T, Hirase T
Diabetes Ther
. 2025 Feb;
PMID: 39951042
Introduction: The objective of this work was to assess the association of tirzepatide with changes in insulin sensitivity and beta-cell function in Japanese patients with type 2 diabetes (T2D). Methods:...
16.
Zhang J, Li A, Quan J, Wu J, Cai H, Ding Y, et al.
Diabetes Ther
. 2025 Feb;
PMID: 39946025
Introduction: Although current guidelines for type 2 diabetes (T2D) underscored the importance of attaining glycemic control and weight management goals, the patient perspectives on achieving these goals remained unclear in...
17.
Winberg D, Tang T, Ramsey Z, Bazzano A, Nauman E, Li J, et al.
Diabetes Ther
. 2025 Feb;
16(3):527-545.
PMID: 39928226
Introduction: Type 2 diabetes mellitus (T2DM) is a common chronic disease with high rates of complications. Although there are successful treatments, rates of medication non-adherence remain high. This study aims...
18.
Nasu R, Oura T, Ohwaki K, Imori M, Furihata K
Diabetes Ther
. 2025 Feb;
16(3):513-526.
PMID: 39928225
Introduction: This analysis aimed to assess the safety and tolerability of insulin efsitora alfa (efsitora, basal insulin Fc, LY3209590) and characterize the pharmacokinetic and pharmacodynamic profiles of efsitora in Japanese...
19.
Panou T, Gouveri E, Popovic D, Papazoglou D, Papanas N
Diabetes Ther
. 2025 Feb;
16(3):371-411.
PMID: 39928224
Diabetic peripheral neuropathy (DPN) is one of the most frequent complications of diabetes mellitus (DM). Its pathogenesis is still not entirely clear. Inflammation is increasingly being appreciated as a key...
20.
Gardner D, Saboo B, Kesavadev J, Mustafa N, Villa M, Mahoney E, et al.
Diabetes Ther
. 2025 Feb;
16(3):349-369.
PMID: 39928223
Diabetes is a growing global health concern with a high prevalence in the Asian and Western Pacific regions. Effective diabetes management mainly relies on self-care practices. However, glycemic control remains...